MARC details
000 -LEADER |
fixed length control field |
01518cam a2200301 4500 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9241206756 |
035 ## - |
-- |
(Sirsi) 9241206756 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 259 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
871015s1982 1 0 eng |
110 2# - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
WHO Study Group on Chemotherapy of Leprosy for Control Programmes. |
245 00 - TITLE STATEMENT |
Title |
Chemotherapy of leprosy for control programmes : |
Remainder of title |
report of a WHO study group [meeting held in Geneva from 12 to 16 October 1981] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
Geneva : |
Name of publisher, distributor, etc. |
World Health Organization, |
Date of publication, distribution, etc. |
1982. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
33 p. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
World Health Organization technical report series ; |
Volume/sequential designation |
no. 675 |
500 ## - GENERAL NOTE |
General note |
Issued in Portuguese as: Publicação científica / Organização Pan-Americana da Saúde ; no. 465. |
500 ## - GENERAL NOTE |
General note |
Russian version of nos. 658-678 bound together (barcode no. 00073789). |
520 3# - SUMMARY, ETC. |
Summary, etc. |
Proposes globally applicable regimens to treat the different groups of multibacillary patients and a further combined regimen designed for the short-term chemotherapy of paucibacillary patients. The report also recommends ways of overcoming the operational problems created by the move from dapsone monotherapy to the complexities of multidrug therapy. |
546 ## - LANGUAGE NOTE |
Language note |
ara eng fre por rus spa. |
561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
History |
WHO monograph |
596 ## - |
-- |
4 |
650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Leprosy |
General subdivision |
drug therapy. |
650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Leprostatic agents. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health Organization. |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
NLM Classification Scheme |
Koha item type |
Books |